Director's Dealing • Apr 25, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Adam Steensberg | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Chief Executive Officer | ||
| b) | Initial notification/Amend ment |
Initial notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc tion monitor |
|||
| a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
||
| b) | LEI1 | 549300ITBB1ULBL4CZ12 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Shares Description of the financial instrument, type of instru ment |
|||
| Identification code | DK0060257814 | |||
| b) | Nature of the transaction | Sale of Shares | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 230.05 | 45,000 | |||
| d) | Aggregated information - Aggregated volume - Price |
45,000 10,352,197.20 DKK |
||
| e) | Date of the transaction | 25, April 2023 |
||
| f) | Place of the transaction | Nasdaq Copenhagen |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.